Industry: Drug Manufacturers - Specialty & Generic
CEO:Mr. Zheng Liang
Full-time employees:20318
City:Shenzhen
Address:Guanlan High-tech Park
IPO:2000-03-09
CIK:
Website:
General Outlook
When we look at how much money they make before expenses, they keep 0.525% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is 0.151%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of 0.120%. This tells us they're good at keeping money after all costs.
Return on Investments
The company's asset efficiency, represented by a robust 0.074% return, is a testament to China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.'s adeptness in optimizing resource deployment. China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.'s utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of 0.162%. Furthermore, the proficiency of China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. in capital utilization is underscored by a remarkable 0.135% return on capital employed.
Stock Prices
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.'s stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $52.3, while its low point bottomed out at $51.6. This variance in figures offers investors a lucid insight into the roller-coaster ride that is China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.'s stock market.
Liquidity Ratios
Analyzing 000999.SZ liquidity ratios reveals its financial health of the firm.
The current ratio of 187.93% gauges short-term asset coverage for liabilities.
The quick ratio (140.47%) assesses immediate liquidity, while the cash ratio (55.74%) indicates cash reserves.
cards.indicator
cards.value
Current Ratio
187.93%
Quick Ratio
140.47%
Cash Ratio
55.74%
Profitability Ratios
000999.SZ profitability indicators offer a lens into its earnings landscape. A pretax profit margin of 15.86% underscores its earnings before tax deductions.
The effective tax rate stands at 16.07%, revealing its tax efficiency.
The net income per EBT, 75.71%, and the EBT per EBIT, 104.99%, provide insights into its earnings hierarchy.
Lastly, with an EBIT per revenue ratio of 15.11%, we grasp its operational profitability.
cards.indicator
cards.value
Pretax Profit Margin
15.86%
Effective Tax Rate
16.07%
Net Income per EBT
75.71%
EBT per EBIT
104.99%
EBIT per Revenue
15.11%
Operational Efficiency
Operational metrics shed light on its business agility. With an operating cycle of 1.88, it details the span from stock purchase to revenue.
The 1 days it takes to settle debts showcases its creditor relations.
Meanwhile, a 1 cash conversion cycle and 287.58% receivables turnover rate reflect its cash flow efficiency and credit management, respectively.
cards.indicator
cards.value
Days of Sales Outstanding
140
Days of Inventory Outstanding
150
Operating Cycle
276.88
Days of Payables Outstanding
71
Cash Conversion Cycle
206
Receivables Turnover
2.88
Payables Turnover
5.14
Inventory Turnover
2.43
Fixed Asset Turnover
3.89
Asset Turnover
0.62
Cash Flow Ratios
Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, 4.81, and free cash flow per share, 4.01, depict cash generation on a per-share basis.
The cash per share value, 9.02, showcases liquidity position.
A payout ratio of 0.35 highlights the portion of earnings distributed as dividends.
Lastly, the operating cash flow sales ratio, 0.18, offers insight into cash flow relative to sales.
cards.indicator
cards.value
Operating Cash Flow per Share
4.81
Free Cash Flow per Share
4.01
Cash per Share
9.02
Payout Ratio
0.35
Operating Cash Flow Sales Ratio
0.18
Free Cash Flow to Operating Cash Flow Ratio
0.83
Cash Flow Coverage Ratio
1.34
Short Term Coverage Ratio
2.72
Capital Expenditure Coverage Ratio
6.03
Dividend Paid and Capex Coverage Ratio
2.54
Dividend Payout Ratio
0.02
Debt and Leverage Ratios
Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 8.54%, highlights its total liabilities relative to assets.
With a debt-equity ratio of 0.17, we discern the balance between debt and equity financing.
The long-term debt to capitalization, 8.10%, and total debt to capitalization, 14.76%, ratios shed light on its capital structure.
An interest coverage of 41.97 indicates its ability to manage interest expenses.
cards.indicator
cards.value
Debt Ratio
8.54%
Debt Equity Ratio
0.17
Long Term Debt to Capitalization
8.10%
Total Debt to Capitalization
14.76%
Interest Coverage
41.97
Cash Flow to Debt Ratio
1.34
Company Equity Multiplier
2.03
Per Share Data
Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 24.99, provides a glimpse into top-line earnings distributed across each share.
Net income per share, 2.91, reflects the portion of profit attributed to each share.
The book value per share, 19.38, represents the net asset value distributed per share, while the tangible book value per share, 15.86, excludes intangible assets.
cards.indicator
cards.value
Revenue Per Share
24.99
Net Income Per Share
2.91
Book Value Per Share
19.38
Tangible Book Value Per Share
15.86
Shareholders Equity Per Share
19.38
Interest Debt Per Share
3.99
Capex Per Share
-0.88
Growth Ratios
Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, 35.31%, indicates top-line expansion, while the gross profit growth, 29.06%, reveals profitability trends.
EBIT growth, 19.57%, and operating income growth, 19.57%, offer insights into operational profitability progression.
The net income growth, 16.50%, showcases bottom-line expansion, and the EPS growth, 16.40%, measures the growth in earnings per share.
cards.indicator
cards.value
Revenue Growth
35.31%
Gross Profit Growth
29.06%
EBIT Growth
19.57%
Operating Income Growth
19.57%
Net Income Growth
16.50%
EPS Growth
16.40%
EPS Diluted Growth
16.40%
Dividends per Share Growth
23.39%
Operating Cash Flow Growth
40.38%
Free Cash Flow Growth
63.67%
10-Year Revenue Growth per Share
214.32%
5-Year Revenue Growth per Share
82.19%
3-Year Revenue Growth per Share
79.39%
10-Year Operating CF Growth per Share
188.29%
5-Year Operating CF Growth per Share
120.82%
3-Year Operating CF Growth per Share
89.77%
10-Year Net Income Growth per Share
142.12%
5-Year Net Income Growth per Share
99.22%
3-Year Net Income Growth per Share
78.59%
10-Year Shareholders Equity Growth per Share
209.20%
5-Year Shareholders Equity Growth per Share
75.17%
3-Year Shareholders Equity Growth per Share
38.17%
10-Year Dividend per Share Growth per Share
282.65%
5-Year Dividend per Share Growth per Share
114.94%
3-Year Dividend per Share Growth per Share
148.83%
Receivables Growth
41.34%
Inventory Growth
104.59%
Asset Growth
48.02%
Book Value per Share Growth
11.51%
Debt Growth
907.93%
R&D Expense Growth
8.01%
SGA Expenses Growth
56.28%
Other Metrics
Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 46,269,540,527, captures the company's total value, considering both debt and equity.
Income quality, 1.48, assesses the reliability of reported earnings.
The sales, general, and administrative to revenue ratio, 0.01, gauges operational efficiency, while the research and development to revenue, 2.62%, highlights investment in innovation.
The ratio of intangibles to total assets, 22.92%, indicates the value of non-physical assets, and capex to operating cash flow, -20.31%, measures reinvestment capability.
cards.indicator
cards.value
Enterprise Value
46,269,540,527
Income Quality
1.48
Sales General and Administrative to Revenue
0.01
Research and Development to Revenue
2.62%
Intangibles to Total Assets
22.92%
Capex to Operating Cash Flow
-20.31%
Capex to Revenue
-3.50%
Capex to Depreciation
-100.41%
Stock-Based Compensation to Revenue
0.34%
Graham Number
35.65
Return on Tangible Assets
9.22%
Graham Net Net
1.84
Working Capital
9,575,027,149
Tangible Asset Value
15,525,048,042
Net Current Asset Value
7,100,775,658
Average Receivables
7,326,259,604.5
Average Payables
2,080,185,012.5
Average Inventory
3,805,682,486
Days Sales Outstanding
128
Days Payables Outstanding
73
Days of Inventory On Hand
157
ROIC
13.07%
ROE
0.15%
Valuation Ratios
Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 2.93, and the price to book ratio, 2.93, reflect the market's valuation relative to the company's book value.
The price to sales ratio, 2.33, provides a perspective on valuation in relation to sales.
Ratios like price to free cash flows, 15.18, and price to operating cash flows, 12.66, gauge market valuation against cash flow metrics.
cards.indicator
cards.value
Price Book Value Ratio
2.93
Price to Book Ratio
2.93
Price to Sales Ratio
2.33
Price Cash Flow Ratio
12.66
Price Earnings to Growth Ratio
2.25
Enterprise Value Multiple
14.47
Price Fair Value
2.93
Price to Operating Cash Flow Ratio
12.66
Price to Free Cash Flows Ratio
15.18
Price to Tangible Book Ratio
2.57
Enterprise Value to Sales
1.89
Enterprise Value Over EBITDA
10.57
EV to Operating Cash Flow
10.96
Earnings Yield
5.86%
Free Cash Flow Yield
6.91%
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
